An image sowing phagocytosis of a cancer cell by macrophages in the presence of a bispecific antibody conjugated drug-loaded nanotherapeutic. Credit: Tanmoy Saha, Brigham and Women’s Hospital Researchers at Brigham and Women’s Hospital have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system’s ability to fight cancer. The team showed promising results for the new therapy in cancer cells in the lab and in mouse lung tumor models, with potential applications for improving care and outcomes for patients with tumors that Read More